Cerba Research has announced a new partnership with Biokortex to leverage patient biological and medical data to support drug developers and CROs with patient identification and recruitment activity.
The benefits of this new partnership include patients’ biological and medical data from over 25 million patients per year from over 1,000 sites located in Europe, Africa, and North America, a platform for screening and companion diagnostic testing across Europe and Africa, and more.
Click here for more information.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.